Epidemiology, HIV and drugs: mathematical models and data. NLM AIDSLINE Important note: Information in this article was accurate in 1992. The state of the art may have changed since the publication date.

Click here to return to AIDSLINE main menu
DonateNow
Print this Article


Epidemiology, HIV and drugs: mathematical models and data.

Br J Addict. 1992 Mar;87(3):371-9. Unique Identifier : AIDSLINE MED/92216631
Blower S; Medley G; Survey Research Center, University of California, Berkeley 94720.

Abstract: The utility of mathematical models in understanding the dynamics of HIV transmission among injecting drug users (IDUs) and their non-IDU sex partners is discussed. We emphasize the need for collaborative relationships between modellers and drug-use researchers, and we stress that models should be based on data in both their formulation and development stages. We outline some of the possible data requirements of transmission models and we highlight the need for the collection of appropriate quantitative data, so that modellers can estimate specific parameters for their models. We believe that discussion of the needs and utility of mathematical modelling will lead to mutually beneficial collaborations between theoreticians and drug-use researchers. These collaborations may aid in the design and the evaluation of effective behavioural or medical intervention strategies.
Keywords: England/EPIDEMIOLOGY Human HIV Infections/PREVENTION & CONTROL/*TRANSMISSION HIV Seroprevalence/*TRENDS *Models, Theoretical Risk Factors *Street Drugs Substance Abuse, Intravenous/COMPLICATIONS/*EPIDEMIOLOGY/ REHABILITATION Support, Non-U.S. Gov't JOURNAL ARTICLEKWDengland/epidemiologyhumanhivinfections/prevention&control/KWDtransmissionhivseroprevalence/KWDtrendsKWDmodels,theoreticalriskfactorsKWDstreetdrugssubstanceabuse,intravenous/complications/KWDepidemiology/rehabilitationsupport,non-uKWDsKWDgov'tjournalarticle
920730
M9270599

Copyright © 1992 - National Library of Medicine. Reproduced under license with the National Library of Medicine, Bethesda, MD.

AEGiS is a 501(c)3, not-for-profit, tax-exempt, educational corporation. AEGiS is made possible through unrestricted funding from Boehringer Ingelheim, Bridgestone/Firestone Charitable Trust, Bristol-Myers Squibb Company, Elton John AIDS Foundation, Gill Foundation, the National Library of Medicine, Quest Diagnostics, Roche and Trimeris, and donations from users like you. Always watch for outdated information. This article first appeared in 1992. This material is designed to support, not replace, the relationship that exists between you and your doctor.

AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.

Copyright ©1980, 1992. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content. .